Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

Medtronic PLC closed $2.15 below its 52-week high ($91.49), which the company reached on September 4th.

Medtronic may be an underrated beneficiary of declining interest rates. That's because as rates come down, it becomes less ...

Medtronic (NYSE: MDT) today announced the publication of its novel approach to studying adaptive deep brain stimulation (aDBS ...

Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy ...

Bridgewater Associates is loading up on shares of ExxonMobil, Medtronic, and Microsoft. Here's what you need to know.

12 ceremony. Axonics Inc. (Nasdaq: AXNX), a maker of medical devices to treat incontinence, said a jury has returned a ...

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

The Court for the Central District of California has sided with Axonics finding the company did not breach Medtronic’s ...

Shares of Medtronic PLC MDT advanced 1.52% to $89.47 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 ...

Axonics, Inc. (AXNX) comes out victorious in a patent trial against Medtronic (MDT), as the jury rules in its favor, awarding ...